-
Popular Diabetes Medicine to Cost Less as Swiss-Major Loses Patent
In good news for over 72 million diabetics in India, cheaper versions of the popular anti-diabetic drug Vildagliptin, have hit the market December 10 onwards. -
Drug Companies Set High Prices for HIV Treatment
Patents and Patients: US pharmaceutical companies are more interested in protecting their valuable drugs patents than treating Indian AIDS sufferers.Comments
No comments yet. Create an account and log in to post a comment.
-
India Rejects US Report, Dubs it Attack on Low-Cost Generic Drugs
A U.S. report blames India as the chief source of counterfeit medicines to the world.
Comments
No comments yet. Create an account and log in to post a comment.
Comments